Publisher
Springer Science and Business Media LLC
Reference10 articles.
1. Rizk JG, Kalantar-Zadeh K, Mehra MR, et al. Pharmaco-immunomodulatory therapy in COVID-19. Drugs. 2020. https://doi.org/10.1007/s40265-020-01367-z.
2. Giannopoulos G, Vrachatis DA, Deftereos SG. Myocardial Injury in COVID-19-Can We Successfully Target Inflammation?. United States: JAMA Cardiol; 2020.
3. Deftereos S, Giannopoulos G, Vrachatis DA, Siasos G, Giotaki SG, Cleman M, et al. Colchicine as a potent anti-inflammatory treatment in COVID-19: can we teach an old dog new tricks? Eur Heart J Cardiovasc Pharmacother. 2020;6(4):255. https://doi.org/10.1093/ehjcvp/pvaa033.
4. Deftereos SG, Siasos G, Giannopoulos G, Vrachatis DA, Angelidis C, Giotaki SG, et al. The GReek study in the Effects of Colchicine in COvid-19 complications prevention (GRECCO-19 study): rationale and study design. Netherlands: Hellenic J Cardiol; 2020.
5. Gendelman O, Amital H, Bragazzi NL, Watad A, Chodick G. Continuous hydroxychloroquine or colchicine therapy does not prevent infection with SARS-CoV-2: Insights from a large healthcare database analysis. Autoimmun Rev. 2020;19:102566.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献